Analytical Data
-
Gene name
rev
- Application
-
Alternative Names
rev;REV1L;DNA repair Protein REV1
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q72501
-
Expression Region
1-116aa
-
AA Sequence
MAGRSGDSDEELIRTVRLIKLLYQSNPPPNPEGTRQARRNRRRRWRERQRQIHSISERILSTYLGRSAEPVPLQLPPLERLTLDCNEDCGTSGTQGVGSPQILVESPTVLESGTKE
-
Molecular Weight
19.2 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Rev is a crucial regulatory protein in the life cycle of the Human Immunodeficiency Virus (HIV) and other retroviruses. It plays a fundamental role in the export of unspliced and partially spliced viral RNA from the nucleus to the cytoplasm, thereby facilitating the production of viral proteins necessary for replication. The study of Rev was initially motivated by the need to understand the mechanisms of HIV pathogenesis and the virus's ability to evade the host's immune responses. Research into Rev has revealed its binding affinity to the Rev response element (RRE) located on the viral RNA, highlighting the intricate interactions between viral components and host cellular machinery. Furthermore, Rev's structure-function relationship has been extensively studied, providing insights into its role as a transcriptional transactivator and its potential as a target for antiviral therapies. Given the ongoing global health crisis posed by HIV/AIDS, understanding the molecular dynamics of Rev not only enhances our knowledge of viral biology but also aids in the development of innovative therapeutic strategies, including small molecules and RNA-based approaches that could inhibit Rev function or disrupt its interactions with RRE. The continued exploration of Rev and its pathways is essential for advancing our efforts in combating HIV, improving treatment regimens, and ultimately contributing to global health outcomes.











